GinkgoBilobaExtract1GeneralDescription:SpecificationStanda***:(1)RoutineTotalGinkgofl***oneglycosides>24%Quercatin:kaemperol0.8--1.5Totalterpenelactones>6%(2)CP2005TotalGinkgofl***oneglycosides>24%Quercatin:kaemperol0.8--1.5Totalterpenelactones>6%Ginkgolicacid<10ppm(3)EGB761TotalGinkgofl***oneglycosides>24%Quercatin:kaemperol0.8--1.5Totalterpenelactones>6%Ginkgolicacid<5ppm(4)MinimalacidTotalGinkgofl***oneglycosides>24%Quercatin:kaemperol0.8--1.5Totalterpenelactones>6%Ginkgolicacid<1ppm(5)EuropeStanda***TotalGinkgofl***oneglycosides22-27%Totalterpenelactones5-7%G.A+G.B+G.C2.8-3.4%B.B2.6-3.2%Ginkgolicacid<5ppm;<1ppmThequalityspecificationofginkgobilobaextractinCP2005:Preparation:Withdrawunderarefluxcondenserofethanol,adsorbwithmacroporousresin,spraytodry,comminute.Character:Yellowishbrowntobrownishpowder,mildlybitterfl***ourTest:Moisture<5.0%Residueonignition<0.8%He***ymetalisnotmorethantwentymillionths,namelylessthan20ppmThepeakarearatiooffl***onoidglycoside,namelyQuercatin:kaemperolshouldbe0.8--1.5Totalginkgoacidshouldbenotmorethantenmillionths,namely10ppmAssay:HighperformanceliquidchromatographyTotalGinkgofl***oneglycosides>24%Thecontentoftotalginkgofl***oneglycosidesisthesumofthecontentofquercatin,kaemperolandisorhamnetin(Quercatin:kaemperol0.8-1.5.Ifitsurpasses1.5,itshouldbesuspectedtoaddquercatin.)Totalterpenelactones>6%Thecontentoftotalterpenelactonesisthesumofthecontentofbilobalide,ginkgolideA,BandC.Function:Promotingbloodcirculation,removingbloodstasisandobstructioninthechannels.ItisindicatedinthepreventionandtreatmentofobstructionofQiinchestandstrokeinducedbybloodstasiswithsymptomsincludingchestpain,palpitati***,stifftongue,dysphasiaoraphasia,hemiparalysis,coronarydisease,anginapectoris,Cardiacinfarction,cerebralcoronarythrombembolia,etc.itiswidelyusedastheadditiveinhealthcareproducts,foods,beveragesandco***eticsetc.2.ManufacturingData:BotanicalName:GinkgobilobaL.Partofplantused:le***es;MethodofManufacturing:maceration,reflux;SolventforExtraction:Ethanol/waterCarrier/Excipient:none;RatioofBotanicaltoNativeExtract:50:13.QualityData:Description:Yellowishbrowntobrownishpowder;mildlybitterfl***our;ParticleSize:80meshLossonDrying:Notmorethan5%He***yMetals<20ppm4.MicrobiologicalInspection:TotalPlateCount<1000cfu/gTotalMoldCount<100cfu/gE.ColiNegativeLiveMiteNegative5.Manufacture:NingboDekangBiochemCo.,Ltd.Mr.ArthurLiTel:+86-574-81625959,13566347633fax+86-574-83033289E-mail:liqingliang_2008@.cn,MSN:hy651025@銀杏葉提取物GinkgoBilobaExtract1GeneralDescription/概述：SpecificationStanda***/規格標準：我公司可供應以下規格：（1）常規產品（未***理銀杏酸）銀杏黃酮≥24%槲皮素與***酚峰比0.8--1.5之間銀杏總內酯≥6%（2）中國***典2005版標準銀杏黃酮≥24%槲皮素與***酚峰比0.8--1.5之間銀杏總內酯≥6%銀杏酸＜10ppm(3)低酸銀杏葉提取物EGB761銀杏黃酮≥24%槲皮素與***酚峰比0.8--1.5之間銀杏總內酯≥6%銀杏酸＜5ppm（4）超低酸銀杏葉提取物銀杏黃酮≥24%槲皮素與***酚峰比0.8--1.5之間銀杏總內酯≥6%銀杏酸＜1ppm5、歐洲標準銀杏葉提取物銀杏黃酮22-27%，銀杏總內酯5-7%G.A+G.B+G.C2.8-3.4%B.B2.6-3.2%銀杏酸<5ppm;<1ppm2005版中國***典銀杏葉提取物質量標準：制法：乙醇回流提取，大孔樹脂吸附，噴幹，粉碎。性狀：淺棕黃色至棕褐色粉末；味微苦。檢查：水分小於5.0%；熾灼殘渣小於0.8%；重金屬不得過百萬分之二十，即20ppm以下。黃酮苷元峰面積比，槲皮素與***素的峰面積比應為0.8至1.5。總銀杏酸不得過百萬分之十，即10ppm。含量測定：***液相色譜法。總黃酮醇苷不得少於24.0%；總黃酮醇苷含量=槲皮素含量+***素含量+異鼠李素含量。（槲皮素與***素的峰面積比應為0.8至1.5之間。如果超過1.5，則應懷疑被人為添加了槲皮素。）萜類內脂總量不得少於6.0%；萜類內脂總量=白果內脂+銀杏內脂A+銀杏內脂B+銀杏內脂C。Function/***：******、通脈舒絡、益***健腦。主要用於腦部，周邊血流迴圈障礙。適應症：1.急慢性腦***能不全，注意力不集中，記憶力***，老年癡呆，及腦血管硬化症狀，中風後遺症。2.耳部之血流及神經障礙，如耳鳴、眩暈和突聾。3.眼部之血流及神經障礙，如***視網膜病***和老年黃斑部退化。4.末稍迴圈障礙，如周邊動脈阻塞症，間歇破行症和手、腳的冰冷***。2.ManufacturingData/生產資料：BotanicalName/植物名：銀杏GinkgobilobaL.Partofplantused/使用部位：葉MethodofManufacturing/生產方法：macerationrefluxSolventforExtraction/提取溶劑：Ethanol/waterCarrier/Excipient/輔料/賦型劑：***RatioofBotanicaltoNativeExtract/原材料與提取物比率：50：13.QualityData/質量數據：Description/性狀：淺棕黃色至棕褐色粉末；味微苦。ParticleSize/粉末細度：80meshLossonDrying/乾燥失重：Notmorethan5%He***yMetals/重金屬：≤20ppm4.MicrobiologicalInspection/微生物：TotalPlateCount＜1000cfu/gTotalMoldCount＜100cfu/gE.ColiNegativeLiveMiteNegative5.Manufacture/生產商:寧波德康生物李慶良Tel:+86-574-81625959,13566347633fax+86-574-83033289E-mail:liqingliang_2008@.cnMSN:hy651025@)